Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Epitalon (Epithalamin)
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural pineal peptide Epithalamin. It has been studied for its potential to activate telomerase and influence aging processes.
Epithalon may activate telomerase, the enzyme responsible for maintaining telomere length. It has also been studied for its effects on melatonin production and circadian rhythm regulation.
Studies by Professor Vladimir Khavinson demonstrated telomerase activation in human somatic cells and increased lifespan in animal models. A 15-year epidemiological study in elderly patients showed reduced mortality with epithalamin treatment. Replication by independent labs remains limited.
Typical Dose
5mg
Range
5-10mg
Frequency
1x/day (subcutaneous)
Route
SubQ or IV
Duration
10-20 day cycles, 2-3x/year
Reconstitution
10mg vial + 2mL bacteriostatic water = 5,000mcg/mL
Notes
Typically administered in 10-day or 20-day cycles, repeated every 4–6 months. Commonly dosed at 5–10 mg per day via subcutaneous injection. Evening dosing may align with melatonin-related effects.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with Epithalon, schedule blood work for key biomarkers, and track your results.
Build Protocol with EpithalonThis platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs